Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Lymphocytic Leukemia (SLL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04434196
What this trial is testing

A Safety and Preliminary Efficacy Study of CC-99282 in Combination With Obinutuzumab in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Celgene 16
Testing effectiveness (Phase 2)Study completedNCT00002880
What this trial is testing

Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 53
Early research (Phase 1)Study completedNCT02242045
What this trial is testing

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Participants With Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas (iNHL) or Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic LeukemiaIndolent Non-Hodgkin LymphomaFollicular Lymphoma+3 more
Gilead Sciences 6
Not applicableUnknownNCT04094051
What this trial is testing

Observational Study of CLL/SLL Treatment and Ibrutinib Treatment of CLL/SLL in Routine Clinical Practice

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
The First Affiliated Hospital with Nanjing Medical University 580
Early research (Phase 1)Ended earlyNCT00014560
What this trial is testing

Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Dartmouth-Hitchcock Medical Center 3
Testing effectiveness (Phase 2)Ended earlyNCT00057954
What this trial is testing

Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Eastern Cooperative Oncology Group 6
Not applicableStudy completedNCT01117142
What this trial is testing

The Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and Healthy Volunteers

Who this might be right for
Lymphoma, Mantle-cellCLL (Chronic Lymphocytic Leukemia)Monoclonal B-Cell Lymphocytosis+2 more
National Heart, Lung, and Blood Institute (NHLBI) 20
Testing effectiveness (Phase 2)Ended earlyNCT02225275
What this trial is testing

Lenalidomide and Obinutuzumab in Treating Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Recurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic Leukemia+1 more
M.D. Anderson Cancer Center 9
Testing effectiveness (Phase 2)Ended earlyNCT02046928
What this trial is testing

Safety, Tolerability and Efficacy of A6 in Patients With Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaCLL+1 more
Ångstrom Pharmaceuticals 5
Early research (Phase 1)Active Not RecruitingNCT03422393
What this trial is testing

Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Michael Choi 24
Testing effectiveness (Phase 2)Study completedNCT00611351
What this trial is testing

Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+4 more
University of Nebraska 5
Testing effectiveness (Phase 2)Study completedNCT01181271
What this trial is testing

Tandem Auto-Allo Transplant for Lymphoma

Who this might be right for
Diffuse, Large B-Cell, LymphomaLymphoma, Low-GradeT-Cell Lymphoma+4 more
Massachusetts General Hospital 42
Early research (Phase 1)Ended earlyNCT00033423
What this trial is testing

Radiolabeled Monoclonal Antibody in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Alabama at Birmingham 18
Testing effectiveness (Phase 2)Study completedNCT00003356
What this trial is testing

Rituximab Plus Interleukin-2 in Treating Patients With Lymphoma

Who this might be right for
Lymphoma
University of Rochester 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT03824483
What this trial is testing

Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Leukemia (SLL)
Memorial Sloan Kettering Cancer Center 230
Testing effectiveness (Phase 2)Looking for participantsNCT04169737
What this trial is testing

Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Recurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic Leukemia+1 more
M.D. Anderson Cancer Center 168
Testing effectiveness (Phase 2)Study completedNCT00003658
What this trial is testing

Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center 60
Not applicableStudy completedNCT04748185
What this trial is testing

Immunogenicity and Safety of Commercially Available Vaccines Against SARS-CoV-2 (COVID-19) in Patients With Hematologic Malignancies

Who this might be right for
Monoclonal B-Cell LymphocytosisChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaB-cell Non Hodgkin Lymphoma+1 more
Mayo Clinic 358
Early research (Phase 1)Study completedNCT00621452
What this trial is testing

Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell Lymphoma+8 more
Fred Hutchinson Cancer Center 12
Early research (Phase 1)WithdrawnNCT00004114
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes
Jonsson Comprehensive Cancer Center
Next Page